Clinical Trials Logo

Clinical Trial Summary

To provide access to maraviroc to patients who have limited or no therapeutic treatment options and to collect more safety data in a broader patient population.


Clinical Trial Description

n/a


Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00426660
Study type Interventional
Source ViiV Healthcare
Contact
Status Completed
Phase Phase 3
Start date February 2007
Completion date June 2010